J&J advances €6bn settlement of talcum powder cancer lawsuits
Courts have rebuffed company’s two previous efforts to resolve the lawsuits
Courts have rebuffed company’s two previous efforts to resolve the lawsuits
Quarterly revenue hit $21.40bn, above market expectations of $21.01bn
Pharmaceutical-related products accounted for almost two-thirds of Irish goods exports last year
President argues Americans pay far too much for their drugs but the power of pharma stands in his way
Banks struggle as investors register concern about the outlook for the euro-zone economy
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
Cork native talks FDI, employee ownership and work-life balance ahead of his retirement
Artificial intelligence could transform the sector, and not everyone subscribes to gloomy forecasts
West Pharmaceutical Services says initiative can make Ireland ‘a powerful exponent’ in new digital technologies
More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out
Euronext Dublin outperforms European peers as a number of its heavy hitters drag it up almost 1.5%
Healthcare company tries to put thousands of lawsuits behind it with latest offer to plaintiffs
Euronext Dublin outperforms international peers on the back of 3 per cent climb by Ryanair
The year was dominated by rollercoaster news stories such as Elon Musk’s turbulent takeover of Twitter, the downfall of Elizabeth Holmes and the numerous cryptocurrency scandals
Agency’s figures also point to partial displacement of trade following UK’s exit from EU
Dublin-headquartered group develops treatments for rare diseases
In a staggering level of exposure 10 per cent of all tax revenue in Ireland is now coming from just 10 American corporations
Group said it hopes to hire 80 new staff at contact lens plant in Plassey, with recruitment under way
A 2018 Reuters investigation found J&J knew for decades that asbestos, a carcinogen, was present in its talc products
Parent company J&J makes almost €420m in net provisions for personal injury claims relating to the antipsychotic drug
Company, part of the Johnson and Johnson Group, specialises in neurovascular care
CEO expects early supplies to be used for Covax supplies as analysts eye shot as booster option
HSE to outline next phase of rollout which will see 400,000 vaccinations a week in June
Allowing J&J for over 50s, along with change in AstraZeneca guidelines, to accelerate vaccinations
No Covid-related deaths reported in the group vaccinated in clinical trial
Review process that could lead to millions more doses becoming available to take place
Johnson & Johnson to ship some Covid-19 vaccines ordered by EU to US for fill/finish
Companies expect approvals as early as October if vaccines deliver on early promise
Company to become leader in medicines treating rare type of high blood pressure
Earlier negotiations between pharmaceutical firms ended a week ago without a deal
Company opens a new €53.2m expanded manufacturing facility
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices